Table 2.
Phase | |||
---|---|---|---|
Outcome | Baseline (SD) | Intervention (SD) | Retention (SD) |
DGI | 11.8 (0.4) | 16.2 (2.3) | 19 (0.0) |
FRT (cm) | |||
Both | 28.9 (2.9) | 28.9 (1.9) | 26.9 (1.6) |
Left | 37.0 (2.3) | 36.8 (1.0) | 34.7 (1.4) |
Right | 36.6 (1.9) | 37.5 (2.0) | 36.0 (2.0) |
EPE (%) | |||
Front | 67.3 (10.2) | 69.9 (6.5) | 80.2 (10.5) |
Right | 69.4 (6.1) | 70.5 (8.6) | 70.0 (2.9) |
Back | 74.1 (5.4) | 84.6 (13.0) | 78.1 (9.6) |
Left | 75.0 (5.7) | 79.3 (12.1) | 73.5 (6.8) |
MXE (%) | |||
Front | 98.5 (8.6) | 99.7 (5.3) | 107.0 (3.8) |
Right | 94.2 (6.9) | 98.7 (6.3) | 100.4 (2.9) |
Back | 100.1 (7.6) | 108.3 (7.2) | 106.6 (10.7) |
Left | 99.8 (8.5) | 101.8 (7.8) | 107.0 (6.7) |
DCL (%) | |||
Front | 67.33 (5.8) | 74.2 (4.8) | 67.5 (7.5) |
Right | 55.02 (11.3) | 66.8 (8.6) | 64.2 (9.4) |
Back | 50.5 (8.6) | 59.1 (3.0) | 60.5 (10.4) |
Left | 68.3 (4.3) | 73.1 (3.6) | 68.5 (4.5) |
DGI dynamic gait index, FRT functional reach test EPE end-point excursion, MXE maximal excursion, DCL directional control